Yuki et al. reported different findings, showing PD-L2 expression in cancer tumors as 0% and in associated lymphocytes as 20.3%, in contrast to PD-L1, which was expressed at 0.8% in tumors and 46.9% in lymphocytes [50]. The gene discussed is CD274; the disease is cancer.